Santurus Investment Group Llc Headquarters
Looking for information about Santurus Investment Group Llc Headquarters? The links below have collected all the necessary data.
Santurus Investment Group, LLC Better Business Bureau ...
- https://www.bbb.org/us/pa/philadelphia/profile/real-estate/santurus-investment-group-llc-0241-143027862
- Santurus Investment Group, LLC. Real Estate. Multi Location Business Find locations. Business Profile. Santurus Investment Group, LLC. 2417 Welsh …
Santurus Investment Group LLC - Manta.com
- https://www.manta.com/c/mtmlkc6/santurus-investment-group-llc
- Santurus Investment Group LLC; 4712 Melrose Street; Philadelphia, PA 19137 ; Visit Website Get Directions Similar Businesses. Detailed Information. Location Type Single Location; Year Established 2008; Annual Revenue Estimate 140000; SIC Code show 6799, Investors, NEC; NAICS Code show ...Employees: 2
Santurus Investment Group, LLC in Philadelphia, PA ...
- https://www.bizapedia.com/pa/santurus-investment-group-llc.html
- Apr 04, 2008 · Santurus Investment Group, LLC is a Pennsylvania Domestic Limited-Liability Company filed On April 4, 2008. The company's filing status is listed as Active and its File Number is 3801399.The company's principal address is 4712 Melrose St, Philadelphia, Philadelphia 19137.Location: Philadelphia
4712 Melrose St, Philadelphia, PA - Santurus Investment ...
- https://clustrmaps.com/a/1eg5uo/
- This address has been used for business registration by Santurus Investment Group LLC. The estimated price of the property is $72,800. The building is two stories high. The price of improvements made to this parcel is $58,878. There are two floors. The alternate variant for this address is 4712 Melrose Str, Philadelphia, PA 19137-1111.DMSLatitude: 40° 0′ 26.1″ N
Santarus - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/santarus
- Contact Email [email protected]. Phone Number 8583145705. Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on five products.Founded: 1996
Santarus Inc - Company Profile and News - Bloomberg Markets
- https://www.bloomberg.com/profile/company/SNTS:US
- Santarus, Inc. focuses on acquiring, developing, and commercializing proprietary products. The Company offers budesonide, bromocriptine mesylate, fenofibrate, omeprazole, and metformin ...
Have you found Santurus Investment Group Llc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.